Explore more publications!

China Signs Off on Fentanyl Precursors Halt

(MENAFN) FBI Director Kash Patel announced Wednesday that Beijing has pledged sweeping enforcement measures targeting the chemical pipeline fueling the global fentanyl crisis, unveiling tangible commitments following his recent diplomatic mission to the Chinese capital.

During a White House briefing, Patel disclosed that negotiations at China's Ministry of Public Security yielded a comprehensive enforcement strategy. "While at Ministry of Public Security headquarters ... the Chinese government agreed on a plan to stop fentanyl precursors," the FBI chief said, detailing his just-completed Beijing visit.

The accord marks a significant escalation in bilateral narcotics control. China has now formally classified and scheduled all 13 chemical precursors integral to fentanyl synthesis, according to Patel's account. The commitment extends beyond precursor scheduling alone: "Furthermore, they have agreed to control seven chemical subsidiaries that are also utilized to produce this lethal drug," he stated.

Stateside enforcement efforts have intensified dramatically. The FBI has confiscated nearly 1,900 kilograms of fentanyl—a staggering 31% surge compared to the corresponding period in the prior year, Patel revealed, underscoring the scale of the narcotics threat and the urgency of the transpacific collaboration.

MENAFN13112025000045017169ID1110337176


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions